Abundance Wealth Counselors Genetic Technologies LTD Transaction History

Abundance Wealth Counselors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$0.0 - $0.02 $0 - $5	-251 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$0.0 - $0.01 $0 - $2	237 Added 1692.86%	251 $1,000
Q1 2021 May 05, 2021	BUY	$0.0 - $0.01 $0 - $0	14 New	14 $43,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

Stay updated on Abundance Wealth Counselors with notifications on news.